An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication

Eur J Clin Invest. 2020 Jul;50(7):e13297. doi: 10.1111/eci.13297. Epub 2020 Jun 19.
No abstract available

Publication types

  • Clinical Trial Protocol

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment*
  • COVID-19*
  • Chloroquine* / therapeutic use
  • Electrocardiography
  • Hospitalization
  • Humans
  • Hydroxychloroquine* / therapeutic use
  • Long QT Syndrome / chemically induced
  • Long QT Syndrome / physiopathology
  • Netherlands
  • Pandemics
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Chloroquine
  • Hydroxychloroquine

Grants and funding